In: BMC Endocrine Disorders, 16 (2016), Nr. 56. pp. 1-7. ISSN 1472-6823
Preview |
PDF, English
Download (630kB) | Lizenz: ![]() |
Abstract
Background: The aim of this study was to investigate the effect of a lifestyle intervention in obesity on the soluble form of the activated leukocyte cell adhesion molecule (sALCAM) and its association with metabolic parameters. Methods: Twenty-nine obese subjects selected from the OPTIFAST®52 program. This program consisted into 2 crucial phases: an initial 12-week active weight reduction phase, followed by a 40-week weight maintenance phase. At baseline, after 12 weeks and at the end of the program, fasting glucose and insulin, total cholesterol, LDL-C, HDL-C, triglycerides, adiponectin, leptin, high sensitivity CRP, sALCAM, homeostasis model assessment-estimated insulin resistance (HOMA-IR) and leptin-to-adiponectin-ratio were determined. Oral glucose tolerance test (OGTT) was performed when indicated. Results: At baseline, the serum concentration of sALCAM was increased and correlated positively with HOMA-IR and negatively with age. At the end of the program, sALCAM concentrations decreased significantly. Multivariate analysis showed that sALCAM significantly correlated with age, glucose concentration after 2 h OGTT and the HOMA-IR. A higher decrease of HOMA-IR during the study was observed in subjects with higher concentration of sALCAM at baseline. Conclusions: sALCAM might be a novel biomarker in obesity that correlates and predicts insulin sensitivity improvement and that can be affected by lifestyle intervention.
Document type: | Article |
---|---|
Journal or Publication Title: | BMC Endocrine Disorders |
Volume: | 16 |
Number: | 56 |
Publisher: | BioMed Central |
Place of Publication: | London |
Date Deposited: | 18 Oct 2016 11:52 |
Date: | 2016 |
ISSN: | 1472-6823 |
Page Range: | pp. 1-7 |
Faculties / Institutes: | Medizinische Fakultät Heidelberg > Medizinische Universitäts-Klinik und Poliklinik |
DDC-classification: | 610 Medical sciences Medicine |